199 related articles for article (PubMed ID: 7611243)
1. Significance of myeloperoxidase in rapidly progressive glomerulonephritis.
Saeki T; Kuroda T; Morita T; Suzuki K; Arakawa M; Kawasaki K
Am J Kidney Dis; 1995 Jul; 26(1):13-21. PubMed ID: 7611243
[TBL] [Abstract][Full Text] [Related]
2. Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases.
Nakabayashi K; Fujioka Y; Nagasawa T; Kimura T; Kojima K; Arimura Y; Yamada A
Clin Exp Nephrol; 2011 Apr; 15(2):226-34. PubMed ID: 21246240
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
4. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
[TBL] [Abstract][Full Text] [Related]
5. Distribution of the granulocyte serine proteinases proteinase 3 and elastase in human glomerulonephritis.
Mrowka C; Csernok E; Gross WL; Feucht HE; Bechtel U; Thoenes GH
Am J Kidney Dis; 1995 Feb; 25(2):253-61. PubMed ID: 7847352
[TBL] [Abstract][Full Text] [Related]
6. The role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis.
Arimura Y; Kawashima S; Yoshihara K; Komagata Y; Kaname S; Yamada A
Clin Exp Nephrol; 2013 Oct; 17(5):634-637. PubMed ID: 23504409
[TBL] [Abstract][Full Text] [Related]
7. Classic and perinuclear anti-neutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis.
Rollino C; Roccatello D; Coppo R; Menegatti E; Basolo B; Giraudo G; Martina G; Piccoli G
Am J Nephrol; 1991; 11(4):318-24. PubMed ID: 1665954
[TBL] [Abstract][Full Text] [Related]
8. [A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane antibody (anti-GBM Ab)].
Kobayashi M; Saito M; Minoshima S; Arimura Y; Nagasawa T
Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):207-11. PubMed ID: 7731110
[TBL] [Abstract][Full Text] [Related]
9. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.
Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M
Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649
[TBL] [Abstract][Full Text] [Related]
11. [Rapidly progressive glomerulonephritis associated with myeloperoxidase specific-antineutrophil cytoplasmic antibody in patients with rheumatoid arthritis : report of three cases].
Yoshihara R; Tanaka Y; Shiozawa K; Hayakawa M; Nagao M; Imura S
Ryumachi; 1996 Oct; 36(5):762-8. PubMed ID: 8969556
[TBL] [Abstract][Full Text] [Related]
12. Analysis of risk epitopes of anti-neutrophil antibody MPO-ANCA in vasculitis in Japanese population.
Suzuki K; Kobayashi S; Yamazaki K; Gondo M; Tomizawa K; Arimura Y; Nakabayashi K; Ozaki S; Yoshida M; Yoshida T; Tsusaka N; Muso E; Okazaki T; Hashimoto H
Microbiol Immunol; 2007; 51(12):1215-20. PubMed ID: 18094540
[TBL] [Abstract][Full Text] [Related]
13. Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Hanamura K; Tojo A; Kinugasa S; Asaba K; Onozato ML; Uozaki H; Fukayama M; Fujita T
Hum Pathol; 2011 May; 42(5):649-58. PubMed ID: 21292302
[TBL] [Abstract][Full Text] [Related]
14. [Case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis].
Yamazaki C; Arai S; Tamura Y; Suzuki Y; Nakajima H; Kojima K; Uchida S
Nihon Jinzo Gakkai Shi; 2009; 51(4):490-5. PubMed ID: 19601559
[TBL] [Abstract][Full Text] [Related]
15. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
16. [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
Bosch X; Mirapeix E; Font J; López-Soto A; Rodríguez R; Vivancos J; Revert L; Ingelmo M; Urbano-Márquez A
Med Clin (Barc); 1994 Mar; 102(11):412-7. PubMed ID: 8182997
[TBL] [Abstract][Full Text] [Related]
17. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
18. Renal expression of adhesion molecules in anca-associated disease.
Arrizabalaga P; Solé M; Abellana R; Ascaso C
J Clin Immunol; 2008 Sep; 28(5):411-9. PubMed ID: 18574676
[TBL] [Abstract][Full Text] [Related]
19. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
20. [An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture's syndrome onset of crescentic glomerulonephritis].
Takeda T; Takeda T; Naiki Y; Yonekawa S; Sakaguchi M; Iwamoto I; Tanaka H; Hasegawa H; Imada A; Kanamaru A; Hiruma S; Maekura S; Hashimoto S; Yamazumi T
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):591-6. PubMed ID: 9893458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
